NEW YORK, Nov. 21, 2024 /PRNewswire/ — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a preeminent national shareholder rights litigation firm, announces that is investigating potential claims against Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ:QTRX) on behalf of Quanterix stockholders.
The investigation concerns whether Quanterix and certain of its officers and/or directors have engaged in securities fraud.
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
Quanterix Corporation develops ultra-sensitive detection systems for use in research and in-diagnostics. The Company offers automated immunoassay technology for detection and quantification of biomarkers in in-vitro and companion diagnostics and blood screening.
On November 12, 2024, following the market’s closure, Quanterix disclosed that it had discovered an error in the capitalization of labor and overhead costs for prior periods, dating back to at least 2021. This error impacted the valuation of its inventory. Consequently, the company advised that the financial statements containing these errors should no longer be considered reliable.
Following this news, Quanterix’s stock price fell by 18.3% closing at $12.40 per share on November 13, 2024.
Wolf Haldenstein has experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas, and offices in New York, Chicago, Nashville and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly lauded by the courts, which have appointed it to major positions in complex securities, multi-district and consolidated litigation.
If you wish to discuss this investigation or have any questions regarding your rights and interests, please immediately contact by telephone at (800) 575-0735 or via e-mail at [email protected].
[email protected] or [email protected]
Tel: (800) 575-0735 or (212) 545-4774
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
SOURCE Wolf Haldenstein Adler Freeman & Herz LLP
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+Newsrooms &Influencers
9k+Digital MediaOutlets
270k+JournalistsOpted In